BF
TGTX icon

BOK Financial’s TG Therapeutics TGTX Stock Holding History

BOK Financial’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.7K Hold
450
– – ﹤0.01% 909
2026
Q1 		$14.9K Sell
450
-853
-65% -$25.4K ﹤0.01% 937
2025
Q4 		$38.8K Hold
1,303
– – ﹤0.01% 867
2025
Q3 		$47.1K Sell
1,303
-962
-42% -$31.7K ﹤0.01% 847
2025
Q2 		$81.5K Hold
2,265
– – ﹤0.01% 778
2025
Q1 		$89.3K Hold
2,265
– – ﹤0.01% 772
2024
Q4 		$65.4K Hold
2,265
– – ﹤0.01% 789
2024
Q3 		$50.3K Buy
+2,265
New +$49.5K ﹤0.01% 814

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

BOK Financial's TGTX Position: Q2 2026 in Review

BOK Financial held its TG Therapeutics (TGTX) position steady in Q2 2026 at 450 shares worth $24.7K. The position accounts for ﹤0.01% of the portfolio, ranked #909.

BOK Financial first reported a position in TGTX in Q3 2024 and has held it in 8 quarters since. The position peaked at $89.3K in Q1 2025. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • BOK Financial held 450 shares of TG Therapeutics worth $24.7K as of Q2 2026.
  • BOK Financial left its TG Therapeutics share count unchanged in Q2 2026.
  • TG Therapeutics made up ﹤0.01% of BOK Financial's portfolio in Q2 2026, its #909 holding.
  • BOK Financial first reported a position in TG Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • BOK Financial's TG Therapeutics position peaked at $89.3K in Q1 2025.
  • 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.